Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer (Q42444701)
Jump to navigation
Jump to search
scientific article published on 12 September 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer |
scientific article published on 12 September 2013 |
Statements
1 reference
Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer (English)
1 reference
Susana Garcia-Recio
Gemma Fuster
Patricia Fernandez-Nogueira
Eva M Pastor-Arroyo
Domiziana Costamagna
Pedro L Fernandez
Pedro Gascón
Vanessa Almendro
12 September 2013
1 reference